CLINICAL_TRIALS
trial_result
· 2012-12-10
Clinical Trial Update: Effect of Age on Latanoprost 0.005% in Patients With Glaucoma [Phase 4]
Summary
This Phase 4 trial from Yale evaluated whether age impacts the effectiveness of latanoprost 0.005% in glaucoma patients, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2012-12-10